Results
The guarantee, in practice.
Each result below came from a qualifying study under our enrollment guarantee. No impressions billed. No clicks billed. Randomized patients only.
30+
indications
Published Results
Across all campaigns to date. The seven published case studies below are our most thoroughly documented: full spend, cost per patient, and outcome reported for each.
The average per-patient fee for a Phase II-III study ranges from $3,000 to $15,000 depending on indication. For most sites, a single randomized patient returns the cost of the campaign.
Your study could be next.
Book a free consultation to see if our guaranteed approach is a good fit for your enrollment goals.
Book a Free ConsultationAll campaigns developed for IRB review and deployed in accordance with FDA guidance on clinical trial advertising.